The Food and Drug Administration (FDA) carried out an inspection of Copinol Enterprises, Inc. in Miami on May 15, focusing on foodborne biological hazards, FDA website data shows.
Findings from the final report confirmed Copinol Enterprises, Inc. was not required to implement any corrective actions regarding its management operations.
The FDA regularly inspects facilities nationwide to assess whether workplaces and products adhere to FDA-regulated standards aimed at safeguarding public health. Inspection outcomes are made publicly available.
According to its website, the FDA is a federal agency primarily tasked with overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
